Jason Haas, Director: Ligand Pharmaceuticals LGND Sell · Filed 06/15

Trade details

Type: Insider sale
Amount: $886,292.88
Shares · price: 3,461 sh · $256.08 a share
Held after: 4,981 sh
Stock: Ligand Pharmaceuticals LGND
Person: Jason HaasDirector
Trade date: 26/06/12
Filed: 26/06/15
Days to filing: 3 days

Sold 41.0% of holdings

Share of holding sold: 41.0%

Ligand Pharmaceuticals trades, last 26 weeks

What else happened in Ligand Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 05/13~07/12

Jason Haas's recent trades

Jason HaasDirector
Planned saleLigand Pharmaceuticals
Planned sale
Ligand Pharmaceuticals
LGND
$2.1M
7,138 sh
$2.1M
Filed 08/12
Traded 08/12
Jason HaasDirector
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$765K
3,000 sh
$765K
Filed 06/15
Traded 06/12
Jason HaasDirector
Planned saleLigand Pharmaceuticals
Planned sale
Ligand Pharmaceuticals
LGND
$1.7M
6,461 sh
$1.7M
Filed 06/12
Traded 06/12
Jason HaasCFO
BuyOdyssey Therapeutics
Buy
Odyssey Therapeutics
ODTX
$20K
1,000 sh
$20K
Filed 05/11
Traded 05/08
Jason HaasCFO
SellSyros Pharmaceuticals
Sell
Syros Pharmaceuticals
SYRS
$28.9K
137,803 sh
$28.9K
Filed 24/11/20
Traded 24/11/18

Jason Haas, Director — sold $886.3K of Ligand Pharmaceuticals LGND · 41.0% of holdings | Whalegun